您现在的位置: 首页> 研究主题> 麻醉药,局部

麻醉药,局部

麻醉药,局部的相关文献在2002年到2021年内共计88篇,主要集中在外科学、药学、神经病学与精神病学 等领域,其中期刊论文88篇、专利文献47164篇;相关期刊46种,包括右江民族医学院学报、实用医学杂志、天津医药等; 麻醉药,局部的相关文献由294位作者贡献,包括张凡、徐康清、施琼等。

麻醉药,局部—发文量

期刊论文>

论文:88 占比:0.19%

专利文献>

论文:47164 占比:99.81%

总计:47252篇

麻醉药,局部—发文趋势图

麻醉药,局部

-研究学者

  • 张凡
  • 徐康清
  • 施琼
  • 李军
  • 李红
  • 杨洋
  • 王庚
  • 程艳欣
  • 袁建虎
  • 赵森明
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 何爱梅
    • 摘要: [目的]探讨腹横筋膜阻滞对肝癌手术患者术后疼痛以及肝肾功能的影响.[方法]选取2017年7月至2020年7月在本院接受手术治疗的肝癌患者90例,采用随机数表法分为观察组(n=45)和对照组(n=45).对照组给予静吸复合全身麻醉,观察组给予腹横筋膜阻滞.比较两组患者治疗后不同时间点视觉模拟评分(VAS)、C反应蛋白(CRP)、肿瘤坏死因子 α(TNF-α)、白细胞介素-6(IL-6)、门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、白蛋白(ALB)、血尿素氮(BUN)、血肌酐(SCr)变化;记录治疗期间患者肝功不全、腹水、切口不愈等并发症发生率.[结果]观察组患者术后4h、8h、12h、24h时VAS评分均低于对照组,差异有统计学意义(P0.05).术后即刻、术后4 h、术后24 h两组患者BUN、SCr均表现为升高后降低,且观察组表达水平均低于对照组(P<0.05).治疗期间,观察组出现肝功不全、腹水、切口不愈等并发症的总发生率低于对照组(6.67%vs26.67%),差异有显著性(P<0.05).[结论]腹横筋膜阻滞用于肝癌手术患者镇痛效果显著,可降低炎性细胞因子水平,保护患者肝、肾功能,利于患者术后快速康复.
    • 袁建虎; 杨洋
    • 摘要: 目的探讨罗哌卡因混合舒芬太尼用于混合痔外剥内扎术后患者自控硬膜外镇痛的适宜配伍。方法收集2019年10月至2020年6月在北京市二龙路医院择期行混合痔外剥内扎术患者120例,ASAⅠ或Ⅱ,年龄18~60岁,性别不限。于L3~4行腰硬联合麻醉,在蛛网膜下腔给予等比重盐酸罗哌卡因7.5 mg,向尾侧留置硬膜外导管。采用随机数字表法将患者随机分为4组,每组30例,镇痛配方分别是:A组0.1%罗哌卡因+舒芬太尼0.4μg/ml,B组0.075%罗哌卡因+舒芬太尼0.4μg/ml,C组0.075%罗哌卡因+舒芬太尼0.3μg/ml,D组0.075%罗哌卡因+舒芬太尼0.2μg/ml。稀释液均为0.9%NaCl注射液250 ml,背景速度5 ml/h,PCA 2 ml/次,锁定15 min。记录术后6、8、12、24、48 h的镇痛效果及不良反应。结果A、B、C组术后各时点VAS评分及48 h内PCA有效按压次数差异均无统计学意义(P均>0.05),且均优于D组(P均0.05),且均低于A组[(0.5±0.4)分、(0.5±0.4)分、(0.6±0.4)分比(2.6±0.5)分,P均<0.05];A、B组恶心呕吐发生率高于C、D组,差异均有统计学意义(P均<0.05)。结论0.075%罗哌卡因混合舒芬太尼0.3μg/ml为混合痔外剥内扎术后患者自控硬膜外镇痛的适宜配伍。
    • 袁建虎; 杨洋
    • 摘要: 目的 探讨罗哌卡因混合舒芬太尼用于混合痔外剥内扎术后患者自控硬膜外镇痛的适宜配伍.方法 收集2019年10月至2020年6月在北京市二龙路医院择期行混合痔外剥内扎术患者120例,ASA Ⅰ或Ⅱ,年龄18~60岁,性别不限.于L3~4行腰硬联合麻醉,在蛛网膜下腔给予等比重盐酸罗哌卡因7.5 mg,向尾侧留置硬膜外导管.采用随机数字表法将患者随机分为4组,每组30例,镇痛配方分别是:A组0.1%罗哌卡因+舒芬太尼0.4μg/ml,B组0.075%罗哌卡因+舒芬太尼0.4 μg/ml,C组0.075%罗哌卡因+舒芬太尼0.3 μg/ml,D组0.075%罗哌卡因+舒芬太尼0.2μg/ml.稀释液均为0.9%NaCl注射液250ml,背景速度5ml/h,PCA2 ml/次,锁定15 min.记录术后6、8、12、24、48 h的镇痛效果及不良反应.结果 A、B、C组术后各时点VAS评分及48h内PCA有效按压次数差异均无统计学意义(P均>0.05),且均优于D组(P均<0.05);B、C、D组改良Bromage评分差异均无统计学意义(P均>0.05),且均低于A组[(0.5±0.4)分、(0.5±0.4)分、(0.6±0.4)分比(2.6±0.5)分,P均<0.05];A、B组恶心呕吐发生率高于C、D组,差异均有统计学意义(P均<0.05).结论 0.075%罗哌卡因混合舒芬太尼0.3μg/ml为混合痔外剥内扎术后患者自控硬膜外镇痛的适宜配伍.
    • 韩欣欣; 汪璐璐; 王子瑞; 赵辛; 王小竞
    • 摘要: 无痛及舒适化诊疗等技术的提出,使局部麻醉药物在临床的应用更加广泛,尤其是在儿童口腔诊疗中的应用.儿童生长发育与成人存在较大的生理差异,在疼痛控制和局部麻醉药物的应用与成人不同.本文就国内外学者关于各类局部麻醉药物在儿童口腔局部麻醉应用中的系统毒性、最大推荐剂量以及舒适化麻醉方法进行综述,旨在为儿童口腔医生临床应用局部麻醉药物提供帮助.
    • 欧超辉; 尹丁叮; 袁小芳; 郑贵浪
    • 摘要: Objective To explore the effects of local anesthetics with different temperatures on labor analgesia and adverse reactions of labor.Methods A total of 102 primiparae were selected from January 30,2017 to January 10,2018 in Shenzhen Baoan Maternal and Child Health Hospital.The 120 primiparae were randomly divided into two groups:observation group (n =52) and control group (n =50) by digits table method.The two groups were treated with continuous epidural anesthesia for labor analgesia,and the local anesthetics used in the two groups were the same,but the temperature of local anethetics were different.The local anesthetics in the control group were at room temperature (24 °C),while the local anesthetics in the observation group were preheated to human body temperature (37 °C).The analgesic effects and adverse reactions were observed in the two groups.The body temperatures and visual analogue scale (VAS) scores were compared at different time points before and after analgesia between the two groups by the variance analysis of repeated measurement data.Incidences of fever,chills,hypotension,nausea and vomiting,pruritus and total adverse reactions were compared by chi-square test or continuity correction of chi-square test.The procedures followed in this study was in accordance with the ethical standards established by the Human Beings Test Committee of Shenzhen Baoan District Maternal and Child Health Hospital,and was approved by the committee (Approval No.QKTLL-2017-04-11).And the clinical research informed consent form was signed with each primipara.Results ①There were no significant differences between two groups in the age,body weight,length of dilatation of cervix before analgesia and body temperature at admission (P>0.05).②The onset time of analgesia in observation group was (11.0±1.3) min,which was obviously shorter than (13.1 ±2.0) min of control group,and the difference was statistically significant (t =6.559,P <0.001).③ The VAS scores of 5 min before analgesia and 15 min,30 min after analgesia in observation group were (9.30±0.42) points,(2.02±0.12) points,and (1.16±0.13) points,respectively,and in control group were (9.23±0.57) points,(23.15± 0.38) points,and (2.84±0.27) points,respectively.The compared results of VAS scores before and after analgesia between two groups showed that there was an interaction between the treatment measures and the time factor (F treatment× time =32.187,P <0.001).The results of further analysis by fixing the time factor showed that there was no significant difference in the VAS score between the two groups 5 min before analgesia (P>0.05),while 15 and 30 min after analgesia,the VAS scores in the observation group both were significantly lower than those in the control group,and the differences were statistically significant (t =20.415,40.281;P < 0.001).And the results of further analysis by fixing the treatment measures factor showed that there were significant differences in VAS scores before and after analgesia both in the observation group and the control group (F=16.324,12.338;P<0.001).④ The compared results of body temperatures before and after analgesia showed that there was no interaction between the treatment measures and the time factor (Ftreatment × time =0.699,P =0.307).There was no significant difference in body temperature at the time of 5 min before analgesia,1 h and 2 h after analgesia (Ftime =0.287,P =0.715).There was no significant difference in the body temperature between the two groups (F treatment=0.365,P =0.644).⑤The incidences of chill,hypotension and total adverse reactions in observation group were 1.9% (1/52),3.8% (2/52),15.4% (8/52) respectively,which were significantly lower than those in control group 16.0% (8/50),18.0% (9/50),50.0% (25/50),and all the differences were statistically significant (x2 =4.651,P =0.031;x2=5.307,P=0.021;x2=13.956,P<0.001).Conclusions Preheating local anesthetics to human body temperature during labor can shorten the onset time of analgesia,improve the analgesic effect,and reduce the risk of adverse reactions.%目的 探讨不同温度局部麻醉药物的分娩镇痛效果及其不良反应发生情况.方法 选取2017年1月30日至2018年1月10日,于深圳市宝安区妇幼保健院分娩的102例初产妇为研究对象.采用随机数字表法,将其随机分为观察组(n=52)与对照组(n=50).2组初产妇分娩均采用连续硬膜外镇痛,采用的局部麻醉药物一致,但是温度不同,对照组局部麻醉药物为室温(24°C),观察组局部麻醉药物预热至人体体温(37°C).观察2组初产妇分娩镇痛效果、不良反应发生情况.2组初产妇分娩镇痛前、后不同时间点的体温、视觉模拟评分量表(VAS)评分比较,采用重复测量资料的方差分析.2组初产妇产时发热、寒战、低血压、恶心呕吐、瘙痒等不良反应发生率及总体不良反应发生率比较,采用x2检验或者连续性校正x2检验.本研究遵循的程序符合深圳市宝安区妇幼保健院人体试验委员会所制定的伦理学标准,得到该委员会批准(批准文号:QKTLL-2017-04-11),分组征得受试者知情同意,并与其签署临床研究知情同意书.结果 ①2组初产妇年龄、体重、分娩镇痛前宫口扩张情况、入院时体温等一般临床资料比较,差异均无统计学意义(P>0.05).②观察组初产妇分娩镇痛起效时间为(11.0±1.3)min,显著短于对照组的(13.1±2.0) min,2组比较,差异有统计学意义(t=6.559,P<0.001).③观察组初产妇分娩镇痛前5 min及分娩镇痛后15、30 min的VAS评分分别为(9.30±0.42)分、(2.02±0.12)分、(1.16±0.13)分,对照组分别为(9.23±0.57)分、(23.15±0.38)分、(2.84±0.27)分,2组初产妇分娩镇痛前、后的VAS评分比较结果显示,处理措施与测定时间因素间存在交互作用(F处理×时间=32.187,P<0.001).若固定测定时间因素,则2组初产妇分娩镇痛前5 min的VAS评分比较,差异无统计学意义(P>0.05),而分娩镇痛后15、30 min,观察组VAS评分均显著低于对照组,差异均有统计学意义(t=20.415、40.281,P<0.001);若固定处理措施因素,则2.组分娩镇痛前、后的VAS评分分别总体比较,差异均有统计学意义(F=16.324、12.338,P<0.001).④对2组初产妇分娩镇痛前、后的体温的比较结果显示,处理措施与测定时间因素间无交互作用(F处理×时间=0.699,P=0.307),初产妇分娩镇痛前5 min及分娩镇痛后1、2h的体温比较,差异无统计学意义(F时间=0.287,P=0.715),2组初产妇体温比较,差异无统计学意义(F处理=0.365,P=0.644).⑤观察组寒战、低血压及总体不良反应发生率分别为1.9%(1/52)、3.8%(2/52)、15.4%(8/52),分别显著低于对照组的16.0%(8/50)、18.0%(9/50)、50.0%(25/50),2组比较,差异均有统计学意义(x2=4.651,P=0.031;x2=5.307,P=0.021;x2=13.956,P<0.001).结论 初产妇分娩时,将局部麻醉药物预热至人体体温,可缩短分娩镇痛起效时间,提高分娩镇痛效果,并且可降低不良反应发生风险.
    • 费海涛; 王淑芬; 周脉涛
    • 摘要: 目的 对比研究超声下行星状神经节阻滞(SGB)与传统药物治疗失眠症的临床效果.方法 将70例失眠症患者分为观察组和对照组,观察组给予SGB,每天1次,6d为1个疗程,对照组口服艾司唑仑片,每天1次,1 mg/次,7d为1个疗程.3个疗程后,观察两组治疗效果、下丘脑-垂体-肾上腺素水平、PSQI量表评分、睡眠质量满意度.结果 观察组痊愈率和总有效率高于对照组(P<0.05),观察组入睡时间、睡眠时间、睡眠效率、睡眠质量、睡眠障碍、日间功能和PSQI评分低于对照组(P<0.05);观察组血清促肾上腺皮质激素释放激素、促肾上腺皮质激素和皮质醇均低于对照组(P<0.05);治疗15 d,观察组满意度高于对照组(P<0.05).结论 超声引导下SGB可显著提高失眠症患者的疗效,降低下丘脑-垂体-肾上腺素水平和PSQI量表评分,提高患者满意度.
    • 雒志明; 肖汉; 袁靖
    • 摘要: 目的 探讨芬太尼联合咪达唑仑在支气管镜检查中的安全性和有效性.方法 选择北京宣武医院2015年1月至2016年12月收治的符合支气管镜检查的132例患者,男69例,女63例,年龄26 ~ 82岁,平均(63±10)岁,分为两组:(1)观察组:66例,男37例,女29例,年龄26~82岁,平均(63±10)岁,在局部麻醉的基础上加用芬太尼联合咪达唑仑静脉麻醉;(2)对照组:66例,男36例,女30例,年龄30 ~ 82岁,平均(63 ± 10)岁,应用2%利多卡因局部麻醉.记录麻醉前以及达到麻醉深度后5 min时患者的心率、平均动脉压及脉搏氧饱和度,并记录支气管镜检查过程中上述指标的波动情况和不良反应.本研究为前瞻性单中心随机对照研究.采用SPSS 19.0统计软件分析数据.统计方法采用t检验和x2检验.结果 观察组支气管镜检查过程中各项指标的波动值:心率为(12.3±2.3)次/min,平均动脉压为(5.9±2.2)mmHg(1 mmHg =0.133 kPa),脉搏氧饱和度为(4.4±1.3)%;对照组的心率为(21.9±1.8)次/min,平均动脉压为(7.1±2.3) mmHg,脉搏氧饱和度为(13.3±4.2)%,各项指标观察组均低于对照组,差异有统计学意义(t值为74.41、7.84和30.48,均P<0.001).观察组麻醉5 min后的心率为(80.0±11.9)次/min,平均动脉压为(95.0±9.7) mmHg,脉搏氧饱和度为(90.0±5.7)%;对照组麻醉5 min后的心率为(90.3±17.0)次/min,平均动脉压为(102.7±12.4) mmHg,脉搏氧饱和度为(96.5±3.0)%,观察组低于对照组,差异有统计学意义(F值分别为7.122、6.988和58.61,均P<0.001).支气管镜检查过程发生恶心、剧咳、屏气例数观察组(6例)少于对照组(27例),检查后对检查过程观察组遗忘例数(52例)优于对照组(0例),且满意度(58例)好于对照组(25例).结论 支气管镜检查过程中,芬太尼联合咪达唑仑麻醉时患者生命体征波动范围小、耐受性好,但麻醉早期对患者的生命体征有一定影响,对适应证的选择要求更加严格.%Objective To study the effectiveness and safety in bronchoscopy under anesthesia with fentanyl combined with midazolam.Methods We randomly allocated 132 patients(male 69,female 63,median age 62.9 years) requiring bronchoscopy in Beijing Xuanwu Hospital into 2 groups during January 2015 to December 2016.The trial group included 66 patients,receiving fentanyl combined with midazolam for anesthesia,while the control group of 66 patients receiving 2% lidocaine for topical anesthesia.In the trial group,there were 37 males and 29 females,with a median age of 63 years (range 26-82).In the control group,there were 36 males and 30 females,with a median age of 62.8 years (range 30-82).The pulse,mean arterial pressure,and the oxygen saturation of the patients were recorded before anesthesia and 5 minutes after deep anesthcsia was reached.Changes of vital signs and adverse reactions during the bronchoscopy were also observed.Results The fluctuation of pulse (12.3 ± 2.3)/min,mean arterial pressure(5.9 ±2.2) mmHg(1 mmHg =0.133 kPa) and oxygen saturation(4.4 ± 1.3) % was lower in the trial group as compared to that of the control group,pulse(21.9 ± 1.8)/min,mean arterial pressure(7.1 ± 2.3) mmHg,oxygen saturation (13.3 ± 4.2) %,P < 0.001.Five minutes after anesthesia,the pulse (80.0 ± 11.9)/min,the mean arterial pressure (95.0 ± 9.7) mmHg and the oxygen saturation (90.0 ± 5.67) % of patients in the trial group were lower than those in the control group [pulse(90.3 ± 17.0)/min,mean arterial pressure (102.7 ± 12.4) mmHg,oxygen saturation (96.5 ± 3.0) %],the differences being statistically significant(P < 0.001).The trial group also showed smaller fluctuation,better tolerance,and fewer adverse reaction sthan the control group.Conciusion Fentanyl combined with midazolam is safe and effective in bronchoscopy with fewer adverse reactions,but its early effect on the vital signs should be monitored and stricter indications may be needed.
    • 任丽洁; 宋心怡; 孙杰森; 孙秀清
    • 摘要: 目的 探讨口腔用局麻药不良反应发生的原因与规律,为临床用药提供参考.方法 收集2015年1月1日至2017年1月31日滨州医学院附属烟台市口腔医院上报国家药品不良反应监测系统的75例阿替卡因肾上腺素注射液不良反应病例资料(均为门诊及住院患者),对性别、年龄、报告类型、给药途径、药品不良反应发生时间、药品用量、临床表现、关联性评价与转归等进行统计分析.结果 在75例不良反应中,女性40例,男性35例,3~10岁年龄段发生较多[33% (25/75)];用药后1~10 min和用药后1d药品不良反应发生率较高,均为20% (15/75),用药后2d次之[15%(11/75)],用药后10~ 21 d不良反应的发生率为8% (6/75),各时间点药品不良反应发生率差异有统计学意义(X2=12.541,P=0.006).阿替卡因肾上腺素注射液不良反应除说明书中已知的不良反应,还出现了新的药品不良反应,主要表现为注射部位溃疡形成[47%(38/81)],其次为注射部位疼痛、肿胀、坏死、瘙痒等皮肤反应,占20%(16/81).结论 阿替卡因肾上腺素注射液的不良反应主要以注射部位溃疡形成为主,其次是注射部位疼痛、皮疹、瘙痒及嗜睡、心悸、冷汗、头晕恶心、低血压等多见,医师在用药时应详细询问病史,密切注意患者的用药安全.%Objective To investigate the causes and clinical manifestation of adverse reaction of articaine hydrochloride and epinephrine tartrate injection.Methods A retrospective analysis was conducted on the adverse drug reactions (ADR) of local anesthetic articaine hydrochloride and epinephrine tartrate injection.Results In 75 cases of adverse reactions,there were 40 cases of female and 35 cases of male.Adverse reactions occured more frequently at the age of 3-10 [33% (25/75)] and 1-10 min and one day after injection,respectively accounting for 20% (15/75),and two days,accounting for 15% (15/75),10-21 days accounting for 8% (6/75).The main manifestations were injection site ulcers,followed by skin reactions such as pain,swelling,necrosis and pruritus at the injection site.Conclusions The main adverse reactions of articaine hydrochloride and epinephrine tartrate injection are the injection site ulceration,followed by injection site pain,rash,pruritus and drowsiness,nausea and dizziness,palpitations,sweat and hypotension.Doctors should ask the medical history in detail and pay close attention to the patient's medication safety.
    • 蒋秋香; 曹慧娟; 邓斌; 张正迪; 施琼; 蔡铁良
    • 摘要: 目的 探讨连续收肌管阻滞联合关节周围浸润镇痛对全膝关节置换术后的疼痛和应激反应的影响.方法 选择2016年2月至12月本院拟行单侧膝关节置换手术的患者60例,随机均分为2组:连续收肌管阻滞组(C组),连续收肌管阻滞联合关节周围浸润镇痛组(C+P组);术中行腰硬联合麻醉.记录术后6、12h、1、2、3、5d静息和活动疼痛视觉模拟评分;记录术前及术后1、2、3、5d白细胞计数、血糖、C-反应蛋白(CRP)变化;记录术后补救性镇痛药用量及不良反应(如神经损伤、局麻药中毒等)情况.结果 C+P组在术后6、12h、1、2d静息VAS评分和术后6、12 h、1、2、3d活动VAS评分明显低于C组,且差异有统计学意义(P<0.05);C+P组血糖和CRP水平在术后1、2、3d明显低于C组,差异有统计学意义(P<0.05).C+P组额外镇痛药使用次数(0.30±0.18)明显低于C组(0.80±0.81) (P<0.05).两组均无明显不良反应.结论 连续收肌管阻滞联合关节周围浸润在膝关节置换术后镇痛效果更完善,疼痛应激反应下降,不良反应少.
    • 蒋露露; 邓文娟; 施琼; 胡宏强
    • 摘要: 目的 探讨超声引导下神经阻滞麻醉联合右美托咪定咪达唑仑镇静用于老年脊柱畸形患者腹股沟疝手术的临床效果,总结麻醉要点,提高麻醉水平.方法 回顾性分析老年脊柱畸形患者腹股沟疝手术麻醉过程,结合文献分析总结可推广的麻醉方法.结果 超声引导下神经阻滞麻醉联合镇静应用于该两例老年脊柱畸形患者术中麻醉效果好,并发症少,随访满意.结论 超声引导下神经阻滞麻醉联合镇静用于老年脊柱畸形患者腹股沟疝手术安全可靠,值得临床推广.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号